Browse studies
Find your next paid study
3 recruiting studies matching your filters
Phase 1
Phase I Multicenter Study of Ruxolitinib and Duvelisib in Relapsed or Refractory T- or NK-Cell Lymphomas
This study will test the safety of ruxolitinib, given at one dose that does not change, and duvelisib, given at different doses, to find out what effects, if a…
T-cell LymphomasNK-Cell LymphomasT-cell Prolymphocytic Leukemia+1 more
Memorial Sloan Kettering Cancer CenterNCT05010005
Phase 2
Phase II Trial of Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
Background: Lymphoma is a type of blood cancer. Blood cell transplant can cure some people with lymphoma. Researchers want to see if they can limit the compli…
Peripheral T-cell LymphomasLymphoproliferative DisordersImmune System Diseases
National Cancer Institute (NCI)NCT03922724
Phase 2
A Phase II Trial of JAK Inhibitor Added to Immunotherapy for Treatment of Relapsed/Refractory T-cell Lymphoma and 9p Amplified Lymphomas
The purpose of this study is to understand and determine if ruxolitinib added to pembrolizumab is safe and effective for the treatment of relapsed or refractor…
Non-Hodgkin LymphomaHodgkin Disease LymphomaNon-Hodgkin Lymphoma Refractory/ Relapsed+5 more
Seda S. ToluNCT07283822